895 results on '"Ting, Jenny P. -Y."'
Search Results
102. Global functional analysis of nucleophosmin in Taxol response, cancer, chromatin regulation, and ribosomal DNA transcription
103. CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo
104. Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues
105. Cryopyrin: In from the Cold
106. Basic Neurochemistry Lecture: PL-1
107. Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity
108. Importance of acidic, proline/serine/threonine-rich, and GTP-binding regions in the major histocompatibility complex class II transactivator: generation of transdominant-negative mutants
109. Agitation by Suffocation: How Hypoxia Activates Innate Immunity via the Warburg Effect
110. Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells
111. Conservation of the promoter region of DRA-like genes from nonhuman primates
112. Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy
113. Biosynthesis and Intracellular Targeting of the Lysosomal Aspartic Proteinase Cathepsin D
114. Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes
115. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma
116. H2-DMα−/− Mice Show the Importance of Major Histocompatibility Complex-bound Peptide in Cardiac Allograft Rejection
117. GTP Binding by Class II Transactivator: Role in Nuclear Import
118. A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter
119. Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR
120. NLRP12 Regulates Anti-viral RIG-I Activation via Interaction with TRIM25
121. Viral DNA Binding to NLRC3, an Inhibitory Nucleic Acid Sensor, Unleashes STING, a Cyclic Dinucleotide Receptor that Activates Type I Interferon
122. NLRX1 Facilitates Histoplasma capsulatum-Induced LC3-Associated Phagocytosis for Cytokine Production in Macrophages
123. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer
124. Leucine-rich repeats of the class II transactivator control its rate of nuclear accumulation
125. Innate Immune Cell Recovery Is Positively Regulated by NLRP12 during Emergency Hematopoiesis
126. NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR
127. Prion-like MAVS aggregation in lupus patients associates with increased interferon-I
128. Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists
129. The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis
130. Correction: Influenza A Virus NS1 Protein Inhibits the NLRP3 Inflammasome
131. Abstract LB-126: Nanoparticle-incorporated STING activator as an immunotherapeutic for PD-L1 resistant triple-negative breast cancer
132. Platelet activating factor as a novel danger signal for activation of NLRP3 inflammasome
133. Particulate Delivery of Innate Immune Agonist for Cancer Immunotherapy
134. The Toll–Like Receptor 2/6 Agonist, FSL–1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome
135. Differential selectivity of CIITA promoter activation by IFN-γ and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-α
136. NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling
137. Multi-omics analyses reveal that HIV-1 alters CD4+T cell immunometabolism to fuel virus replication
138. Akt-dependent regulation of NF-[kappa]B is controlled by mTOR and Raptor in association with IKK
139. A noncanonical function of cGAMP in inflammasome priming and activation
140. NLRX1 promotes immediate IRF1-directed antiviral responses by limiting dsRNA-activated translational inhibition mediated by PKR
141. Erratum: NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth
142. Dectin-2 is a primary receptor for NLRP3 inflammasome activation in dendritic cell response to Histoplasma capsulatum
143. A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination
144. NLRX1 negatively modulates type I IFN to facilitate KSHV reactivation from latency
145. NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes
146. Innate Immune Cell Recovery Is Positively Regulated by NLRP12 during Emergency Hematopoiesis
147. An NLRP3 Mutation Causes Arthropathy and Osteoporosis in Humanized Mice
148. NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-lambda B signaling
149. NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-lambda B signaling
150. Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.